Romania, strategic market for Glenmark Pharmaceuticals Ltd

Romania ranks first in Central and Eastern Europe based on the company Glenmark Pharmaceuticals Ltd’s turnover trend, according to a press release remitted to “Nine O’Clock”. The other key-countries in the region in which the company operates are Poland, the Czech Republic and Slovakia. Glenmark Pharmaceuticals Romania has doubled its sales in the past two years, while relying exclusively on local funding. In under three years since its entry on the market (in 2008), Glenmark Pharmaceuticals has swept from the 99th to the 41st position on the pharmaceutical market and to 15th place on the generics market.

Related posts

Tarom aims at zero profit in 2011


Raiffeisen, EUR 30 M profit in Romania in Q1

Nine O' Clock

Over 460,900 unemployed officially registered on July 31

Nine O' Clock

Leave a Comment